Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.61 |
| ▸ | CA12 | O43570 | 3/20 | 0.48 |
| ▸ | CA1 | P00915 | 3/20 | 0.48 |
| ▸ | CA2 | P00918 | 3/20 | 0.48 |
| ▸ | CA7 | P43166 | 3/20 | 0.48 |
| ▸ | CA9 | Q16790 | 3/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.48 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ESR1 | P03372 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | ACHE | P22303 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1719721 | 0.97 | TSHR (0.59) | TSHRMAPK1CA12CA1CA2 | |
| SCHEMBL7198377 | 0.95 | TSHR (0.57) | TSHRMAPK1CA12CA1CA2 | |
| SCHEMBL522412 | 0.92 | TSHR (0.53) | TSHRMAPK1CA12CA1CA2 | |
| SCHEMBL27511609 | 0.90 | TSHR (0.53) | TSHRMAPK1CA12CA1CA2 | |
| SCHEMBL2878001 | 0.90 | TSHR (0.53) | TSHRMAPK1CA12CA1CA2 | |
| SCHEMBL523604 | 0.90 | TSHR (0.53) | TSHRMAPK1CA12CA1CA2 | |
| SCHEMBL14271057 | 0.88 | TSHR (0.52) | TSHRMAPK1CA12CA1CA2 | |
| SCHEMBL505374 | 0.88 | TSHR (0.52) | TSHRMAPK1CA12CA1CA2 | |
| SCHEMBL505263 | 0.88 | TSHR (0.52) | TSHRMAPK1CA12CA1CA2 | |
| SCHEMBL29154303 | 0.88 | TSHR (0.52) | TSHRMAPK1CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119500248-A | Supported metal oxide catalyst and preparation method and application thereof | 万华化学集团股份有限公司 | 2025-02-25 | — | — | CN | claimed |
| CN-105753705-A | Mechanical device for production of dimethyl tetrafluoroterephthalate | 江苏维尤纳特精细化工有限公司 | 2016-07-13 | — | — | CN | claimed |
| CN-103641686-B | Synthetic method of 2,3,5,6-tetrafluoro-1,4-benzenedimethanol | LIANYUNGANG CCA CHEMICAL CO LTD | 2015-07-01 | — | — | CN | claimed |
| CN-204385107-U | Novel dimethyl tetrafluoroterephthalate production equipment | JIANGSU WEUNITE FINE CHEM CO LTD | 2015-06-10 | — | — | CN | claimed |
| CN-103641686-A | Synthetic method of 2,3,5,6-tetrafluoro-1,4-benzenedimethanol | LIANYUNGANG CCA CHEMICAL CO LTD | 2014-03-19 | — | — | CN | claimed |
| CN-103483199-A | Preparation method of tetrafluoroterephthalate | ZHEJIANG CHEMSYN PHARM CO LTD | 2014-01-01 | — | — | CN | claimed |
| CN-121021771-A | Degradable high-permeability protective glasses material and preparation method thereof | 广东金海纳实业有限公司 | 2025-11-28 | — | — | CN | disclosed |
| CN-119500248-A | Supported metal oxide catalyst and preparation method and application thereof | 万华化学集团股份有限公司 | 2025-02-25 | — | — | CN | disclosed |
| CN-114751807-B | Preparation process of 2,3,5, 6-tetrafluorobenzyl alcohol | 忠同科技(大连)有限公司 | 2023-08-22 | — | — | CN | disclosed |
| CN-113797977-B | Ruthenium catalyst and application thereof | 沈阳中化农药化工研发有限公司 | 2022-11-29 | — | — | CN | disclosed |
| CN-114751807-A | Novel efficient preparation process of 2,3,5, 6-tetrafluorobenzyl alcohol | 忠同科技(大连)有限公司 | 2022-07-15 | — | — | CN | disclosed |
| CN-113801019-A | Method for preparing poly-fluorobenzyl methyl ether | 沈阳中化农药化工研发有限公司 | 2021-12-17 | — | — | CN | disclosed |
| CN-113797977-A | Ruthenium catalyst and application thereof | 沈阳中化农药化工研发有限公司 | 2021-12-17 | — | — | CN | disclosed |
| CN-101321719-A | Process for producing tetrafluoroterephthalic acid difluoride | SUMITOMO CHEMICAL CO (JP) | 2008-12-10 | — | — | CN | disclosed |
| CN-101321720-A | Method for producing tetrafluoroterephthalic acid difluoride | SUMITOMO CHEMICAL CO (JP) | 2008-12-10 | — | — | CN | disclosed |
| EP-1961729-A1 | METHOD FOR PRODUCING TETRAFLUOROTEREPHTHALIC ACID DIFLUORIDE | Sumitomo Chemical Company, Limited (JP) | 2008-08-27 | — | — | EP | disclosed |
| US-20070213570-A1 | reacting a halogen-substituted terephthalic acid diester with a borohydride compound in the presence of an alcohol and a solvent | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-09-13 | — | — | US | disclosed |
| CN-101001823-A | Process for making halogen substituted benzenedimethanol | SUMITOMO CHEMICAL CO (JP) | 2007-07-18 | — | — | CN | disclosed |
| EP-1783108-A1 | METHOD FOR PRODUCING HALOGEN-SUBSTITUTED BENZENEDIMETHANOL | Sumitomo Chemical Company, Limited (JP) | 2007-05-09 | — | — | EP | disclosed |
| WO-2003042148-A2 | PROCESS FOR PRODUCING BISBENZIL COMPOUNDS | SHOWA DENKO K. K. (JP) | 2003-05-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070213570-A1 | reacting a halogen-substituted terephthalic acid diester with a borohydride compound in the presence of an alcohol and a solvent | ADH1A, ADH1C, CYP4A11 | TSHR 79/4885MAPK1 1460/4885CA12 563/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.